secwatch.observer — SEC 8-K summary
======================================

Issuer:     REPLIGEN CORP (RGEN)
CIK:        0000730272
Form:       8-K
Filed at:   2022-11-01T23:59:59+00:00
Accession:  0001193125-22-274508
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Repligen Q3 revenue $200.7M (+13% YoY); raises FY revenue guidance to $795-$805M
--------------------------------------------------------------------------------

- Revenue $200.7M, +13% reported, +19% constant currency, +16% organic; base business up 29% YoY.
- GAAP EPS $0.71; adjusted EPS $0.77 (vs $0.78 Q3 2021); GAAP gross margin 56.9%.
- FY 2022 revenue guidance raised to $795-$805M (from $790-$810M); base business growth raised to 33%-34%.
- Adjusted EPS guidance narrowed to $3.15-$3.20 from $3.13-$3.20; operating income guidance lowered to $231-$235M.
- Signed 15-year real-time process monitoring deal with DRS Daylight Solutions; extended Purolite affinity ligand agreement to 2032.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/730272/000119312522274508/0001193125-22-274508-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/730272/000119312522274508/d394510d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-274508

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer